RMD:NYSE
ResMed
US$234.60
arrow_upward
+1.98%(+4.55) 1 天
US$234.60
0.00% (0.00)
bedtime盘后交易
休市： 10月12日, GMT-4 16:00:06 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 RMD 生成关键数据洞见…
开盘价
US$231.74
最高价
US$235.98
最低价
US$230.08
市值
329.94亿
平均成交量
120.01万
成交量
284.00
股息
1.13%
季度股息
US$0.66
除息日
2026年8月20日
市盈率
22.49
52 周最高价
US$277.67
52 周最低价
US$180.26
每股收益
US$10.43
Beta 版
0.75
流通股数
1.41亿
员工人数
1万
开盘价
US$231.74
最高价
US$235.98
最低价
US$230.08
市值
329.94亿
平均成交量
120.01万
成交量
284.00
股息
1.13%
季度股息
US$0.66
除息日
2026年8月20日
市盈率
22.49
52 周最高价
US$277.67
52 周最低价
US$180.26
每股收益
US$10.43
Beta 版
0.75
流通股数
1.41亿
员工人数
1万
新闻报道
来自网络来源和新闻合作伙伴
Benzinga
·
1天前
ResMed Q4 2026 Earnings Call Transcript
Investing.com Nigeria
·
2天前
Form 144 RESMED INC For: 10 October By Investing.com
资料
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
ResMed简介